Whittemore Peterson Institute

Whittemore Peterson Institute (WPI) is a biomedical research organization located in Reno, Nevada, United States. It was established with the primary goal of researching and finding treatments for chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME), and other related diseases. The institute is named after the Whittemore family, who were instrumental in its founding, and Dr. Daniel Peterson, a physician renowned for his work with CFS/ME patients.

History[edit | edit source]

The Whittemore Peterson Institute was founded in 2005 by Annette Whittemore, in honor of her daughter who suffers from CFS/ME, and in collaboration with Dr. Daniel Peterson, a specialist in the disease. The institute was one of the first research facilities dedicated to studying CFS/ME, aiming to improve the diagnosis, treatment, and understanding of this complex illness.

Research and Contributions[edit | edit source]

WPI has been involved in various research projects focusing on the underlying causes of CFS/ME, including investigations into the role of infectious agents, immune system abnormalities, and genetic factors. One of the institute's most notable, yet controversial, contributions was the publication of a study in 2009 that suggested a link between a retrovirus called XMRV (Xenotropic Murine Leukemia Virus-related Virus) and CFS/ME. However, subsequent research by other scientists failed to replicate these findings, and the original paper was retracted, raising questions about the validity of the study.

Despite this setback, WPI has continued its research efforts, exploring other potential causes and treatments for CFS/ME and related conditions. The institute also collaborates with other research organizations and advocates for increased funding and awareness for CFS/ME research.

Facilities[edit | edit source]

The Whittemore Peterson Institute is located within the University of Nevada, Reno's Center for Molecular Medicine. This location facilitates collaboration with university researchers and provides access to state-of-the-art laboratory facilities.

Impact and Controversy[edit | edit source]

WPI's work has had a significant impact on the CFS/ME community, providing hope to many patients and families affected by the disease. However, the institute has also faced criticism, particularly regarding the XMRV study. Critics argue that the controversy surrounding the study has detracted from the credibility of CFS/ME research as a whole.

Despite the challenges, WPI remains committed to its mission of advancing research and improving the lives of those affected by CFS/ME and related diseases.